Data monitoring committees for clinical trials and the role of the statistician

54:11
 
Share
 

Manage episode 285666923 series 2400265
By Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry, Alexander Schacht, Benjamin Piske, and Leaders in the pharma industry. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
Interview with David Kerr

Join us while we discuss these questions with David and learn more about the following points:

  • How did David get to this position as a biostatistician at a CRO?
  • How is it made sure that information from the DMC stays within the DMC?
  • What is David's most challenging and most exciting experience he had while working in a DMC setting?
  • When working on open-label trials, it is sometimes requested to “artificially” blind the date but have a DMC review the unblinded data. Has he come across these settings as well, and what’s the challenge he sees here?

References:

https://www.linkedin.com/in/dmcdavid/

https://www.cytel.com/blog/0-key-qualifications-for-independent-statisticians-reporting-to-the-dmc

Listen to this episode and share it with your friends and colleagues!

200 episodes